Nanōmix rapid POC tests utilize an innovative platform incorporating highly sensitive, low cost carbon nanostructure biosensors that can be used for a wide range of assays and sample types.
These tests have the potential to not only curtail the Ebola epidemic but prevent another one in the years ahead. They are significantly faster, cheaper, higher performing and can be deployed in far many more locations than the current standard PCR test in use in West Africa and the US. They produce results in minutes, do not require a lab setting and have been successfully field tested in the region. The tests are also able to differentiate between Ebola and other viruses like Malaria and Lassa. More information is available here.